| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-10-28 | SCHEDULE 13G | Q32 Bio Inc. | — | — | view → |
| 2026-10-28 | SCHEDULE 13G | CADIZ INC | — | — | view → |
| 2026-10-28 | SCHEDULE 13G | USA TODAY Co., Inc. | — | — | view → |
| 2026-10-28 | SCHEDULE 13G | Liberty Live Holdings, Inc. | — | — | view → |
| 2026-10-28 | SCHEDULE 13G | Jasper Therapeutics, Inc. | — | — | view → |
| 2026-10-15 | SCHEDULE 13D/A | Nuveen Minnesota Quality Municipal Income Fund | 100.00% | 478 | view → |
| 2026-10-07 | SCHEDULE 13G | ACCENDRA HEALTH INC/VA/ | — | — | view → |
| 2026-10-05 | SCHEDULE 13D/A | Nuveen Quality Municipal Income Fund | 52.50% | 7,495 | view → |
| 2026-10-02 | SCHEDULE 13D/A | Nuveen Municipal Credit Opportunities Fund | 50.70% | 2,050 | view → |
| 2026-09-17 | SCHEDULE 13D/A | PIMCO CALIFORNIA MUNICIPAL INCOME FUND | 79.40% | 1,920 | view → |
| 2026-08-26 | SCHEDULE 13D/A | PIMCO NEW YORK MUNICIPAL INCOME FUND II | 100.00% | 760 | view → |
| 2026-08-26 | SCHEDULE 13D/A | PIMCO MUNICIPAL INCOME FUND II | 79.50% | 3,860 | view → |
| 2026-08-03 | SCHEDULE 13G | Total Return Securities Fund | — | — | view → |
| 2026-08-03 | SCHEDULE 13G | Fulcrum Therapeutics, Inc. | — | — | view → |
| 2026-08-03 | SCHEDULE 13G | CytomX Therapeutics, Inc. | — | — | view → |
| 2026-08-03 | SCHEDULE 13G | IREN Ltd | — | — | view → |
| 2026-08-03 | SCHEDULE 13G | Inhibrx Biosciences, Inc. | — | — | view → |
| 2026-08-03 | SCHEDULE 13G | BLACKROCK CREDIT ALLOCATION INCOME TRUST | — | — | view → |
| 2026-08-03 | SCHEDULE 13G | Research Alliance Corp III | — | — | view → |
| 2026-08-03 | SCHEDULE 13G | FRANKLIN STREET PROPERTIES CORP /MA/ | — | — | view → |
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →